
start-up receives €10 million in seed funding for 1st-in-class therapy for ALS | Fundamental pharmaceutical therapy aims to protect nerve cells from disease
FundaMental Pharma, a preclinical neuroscience spin-out company from the University of Heidelberg, Germany, has just…